Study Summary
This trial will compare two vaccine regimens to the standard in adults and adolescents to see which one is better.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
6 Primary · 13 Secondary · Reporting Duration: Day 1 through Day 394
Trial Safety
Phase-Based Safety
Side Effects for
Awards & Highlights
Trial Design
2 Treatment Groups
4
1 of 2
5
1 of 2
Active Control
Experimental Treatment
400 Total Participants · 2 Treatment Groups
Primary Treatment: 5 · No Placebo Group · Phase 2
Trial Logistics
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 12 - 50 · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
Texas | 60.0% |
Maryland | 20.0% |
Washington | 20.0% |
What portion of applicants met pre-screening criteria?
Did not meet criteria | 80.0% |
Met criteria | 20.0% |
What site did they apply to?
University of Texas Medical Branch - Division of Infectious Disease | 25.0% |
University of Texas Medical Branch | 25.0% |
Kaiser Permanente Washington Health Research Institute | 25.0% |
Other | 25.0% |
Why did patients apply to this trial?
- "I am interested in helping medical advancement"
- "I am involved with different types of studies through the years. Trying to have some extra cash"
- "I saw the opportunity to sign up for these trials and I really want to help if I can to advance medicine. I also could use the extra income."
How many prior treatments have patients received?
0 | 33.3% |
1 | 33.3% |
3+ | 33.3% |
Frequently Asked Questions
Is this research endeavor open to elderly individuals over eighty-five years of age?
"Participants must be between 12 and 50 years of age to qualify for this clinical trial." - Anonymous Online Contributor
Could I be a viable participant in this experiment?
"This trial is searching for 400 volunteers between the ages of 12 and 50 who are currently living with monkeypox. Qualified patients must meet these criteria in order to participate." - Anonymous Online Contributor
Are there any available vacancies in this trial for participants?
"As indicated on clinicaltrials.gov, this medical study is not presently accepting participants. Initially posted in March 15th2023 and last updated February 13th 2023, the trial has yet to begin recruiting patients. However there are 12 other trials that are actively seeking enrolment at the present moment." - Anonymous Online Contributor
How many medical sites are currently administering this research trial within the state?
"A number of medical centres are taking part in this trial, including The George Washington University Medical Faculty Associates - Infectious Diseases located in the District Of Columbia and National Institutes of Health's Clinical Centre as well as their Laboratory Of Immunoregulation. In addition, Brigham and Women's Hospital is accepting participants for this clinical research study. Altogether there are 13 sites recruiting patients." - Anonymous Online Contributor
What potential risks and side effects are associated with the use of 5?
"A score of 2 was attributed to the safety profile of compound 5, as it is presently being tested in a Phase 2 clinical trial. That said, there does exist data that supports its security but no evidence yet for its efficacy." - Anonymous Online Contributor